Acute hypertension: A systematic review and appraisal of guidelines

Ochsner Journal

Volumn 14, Issue 4, 2014, Pages 655-663

  Pak, Kirk J ^a   Hu, Tian ^b   Fee, Colin ^a   Wang, Richard ^c   Smith, Morgan ^c   Bazzano, Lydia A ^a,b,c  

^a OCHSNER CLINIC FOUNDATION   (United States)

^b TULANE UNIVERSITY   (United States)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Acute disease; Arterial pressure; Blood pressure; Emergency treatment; Hypertension malignant; Practice guidelines as topic

Indexed keywords

ANTIHYPERTENSIVE AGENT; LABETALOL; NITROPRUSSIDE SODIUM;

ADVERSE OUTCOME; ARTICLE; BLOOD PRESSURE REGULATION; CONTINUOUS INFUSION; DISEASE CLASSIFICATION; DRUG CHOICE; EMERGENCY WARD; EVIDENCE BASED MEDICINE; FOLLOW UP; HEALTH CARE POLICY; HEALTH CARE QUALITY; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; MEAN ARTERIAL PRESSURE; MORBIDITY; MORTALITY; ORGAN INJURY; OUTCOME ASSESSMENT; OUTPATIENT CARE; PATIENT CARE; PATIENT COMPLIANCE; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; QUALITY CONTROL; RECURRENCE RISK; RISK REDUCTION; SYSTEMATIC REVIEW; TARGET ORGAN; VALIDATION PROCESS;

EID: 84916884517     PISSN: 15245012     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005 Jan 15-21;365(9455):217-223.
2. James PA, Oparil S, Carter BL, et al. 2014 Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014 Feb 5;311(5):507-520. Erratum in: JAMA. 2014 May 7;311(17):1809.
3. Dasgupta K, Quinn RR, Zarnke KB, et al. The 2014 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Can J Cardiol. 2014 May;30(5):485-501.
4. Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013 Jul;34(28): 2159-2219.
5. Weber MA, Schiffrin EL, White WB, et al. Clinical practice guidelines for the management of hypertension in the community: a statement by the American Society of Hypertension and the International Society of Hypertension. J Clin Hypertens (Greenwich). 2014 Jan;16(1):14-26.
6. World Health Organization (WHO). Prevention of Cardiovascular Disease: Guidelines for Assessment and Management of Cardiovascular Risk. Geneva, Switzerland: WHO Press; 2007. http://www.who.int/cardiovascular_diseases/guidelines?Full%20text.pdf. Accessed September 19, 2014.
7. Whitworth JA; World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens. 2003 Nov;21(11): 1983-1992.
8. British Columbia Ministry of Health. Hypertension-Detection, Diagnosis and Management. Guidelines & Protocols Advisory Committee, Medical Services Commission. http://www.bcguidelines.ca/guideline_hypertension.html. February 15, 2008. Accessed September 19, 2014.
9. National Heart Foundation of Australia. Guide to Management of Hypertension 2008: Assessing and Managing Raised Blood Pressure in Adults. http://www.heartfoundation.org.au?SiteCollectionDocuments?HypertensionGuidelines2008to2010Update.pdf. Updated December 2010. Accessed September 19, 2014.
10. Flack JM, Sica DA, Bakris G, et al. Management of high blood pressure in Blacks: an update of the International Society on Hypertension in Blacks consensus statement. Hypertension. 2010 Nov;56(5):780-800.
11. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003 Dec; 42(6):1206-1252.
12. K/DOQI Workgroup. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis. 2005 Apr;45(4 Suppl 3):S1-S153.
13. Pickering TG, Hall JE, Appel LJ, et al. Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension. 2005 Jan;45(1): 142-161.
14. Shorr AF, Zilberberg MD, Sun X, Johannes RS, Gupta V, Tabak YP. Severe acute hypertension among inpatients admitted from the emergency department. J Hosp Med. 2012 Mar;7(3):203-210.
15. Kuppasani K, Reddi AS. Emergency or urgency? Effective management of hypertensive crises. JAAPA. 2010 Aug;23(8): 44-49.
16. Owens WB. Blood pressure control in acute cerebrovascular disease. J Clin Hypertens (Greenwich). 2011 Mar;13(3):205-211.
17. Zampaglione B, Pascale C, Marchisio M, Cavallo-Perin P. Hypertensive urgencies and emergencies. Prevalence and clinical presentation. Hypertension. 1996 Jan;27(1):144-147.
18. Saguner AM, Dür S, Perrig M, et al. Risk factors promoting hypertensive crises: evidence from a longitudinal study. Am J Hypertens. 2010 Jul;23(7):775-780.
19. Vilela-Martin JF, Vaz-de-Melo RO, Kuniyoshi CH, Abdo AN, Yugar-Toledo JC. Hypertensive crisis: clinical-epidemiological profile. Hypertens Res. 2011 Mar;34(3):367-371.
20. Brouwers MC, Kho ME, Browman GP, et al. AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ. 2010 Dec 14;182(18):E839-E842.
21. Brouwers MC, Kho ME, Browman GP, et al. Development of the AGREE II, part 1: performance, usefulness and areas for improvement. CMAJ. 2010 Jul 13;182(10):1045-1052.
22. Brouwers MC, Kho ME, Browman GP, et al. Development of the AGREE II, part 2: assessment of validity of items and tools to support application. CMAJ. 2010 Jul 13;182(10): E472-E478.
23. Appraisal of Guidelines for Research and Evaluation (AGREE) Enterprise website. http://www.agreetrust.org. Published 2003. Updated August 14, 2014. Accessed September 19, 2014.
24. Haran C, van Driel M, Mitchell BL, Brodribb WE. Clinical guidelines for postpartum women and infants in primary care-a systematic review. BMC Pregnancy Childbirth. 2014 Jan 29;14:51.
25. Lo Vecchio A, Giannattasio A, Duggan C, et al. Evaluation of the quality of guidelines for acute gastroenteritis in children with the AGREE instrument. J Pediatr Gastroenterol Nutr. 2011 Feb;52(2): 183-189.
26. Greuter MJ, van Emmerik NM, Wouters MG, van Tulder MW. Quality of guidelines on the management of diabetes in pregnancy: a systematic review. BMC Pregnancy Childbirth. 2012 Jun 28;12:58.
27. Bouwmeester W, van Enst A, van Tulder M. Quality of low back pain guidelines improved. Spine (Phila Pa 1976). 2009 Nov 1; 34(23):2562-2567.
28. Wolf SJ, Lo B, Shih RD, Smith MD, Fesmire FM; American College of Emergency Physicians Clinical Policies Committee. Clinical policy: critical issues in the evaluation and management of adult patients in the emergency department with asymptomatic elevated blood pressure. Ann Emerg Med. 2013 Jul;62(1):59-68.
29. National Clinical Guideline Centre. Hypertension: The Clinical Management of Primary Hypertension in Adults. Update of clinical guidelines 18 and 34. NICE Clinical Guideline 127. National Institute for Health and Clinical Excellence (NICE), National Health Service. London, England: Royal College of Physicians; 2011. http://www.ncbi.nlm.nih.gov/books/NBK83274/. Accessed September 19, 2014.
30. Weder AB. Treating acute hypertension in the hospital: a Lacuna in the guidelines. Hypertension. 2011 Jan;57(1):18-20.
31. Varon J. Hypertensive emergencies: time for guidelines. Crit Care Shock. 2008;11(4):127-128.
32. Cherney D, Straus S. Management of patients with hypertensive urgencies and emergencies: a systematic review of the literature. J Gen Intern Med. 2002 Dec;17(12):937-945.
33. Grossman E, Messerli FH, Grodzicki T, Kowey P. Should a moratorium be placed on sublingual nifedipine capsules given for hypertensive emergencies and pseudoemergencies? JAMA. 1996 Oct 23-30;276(16):1328-1331.
34. O’Mailia JJ, Sander GE, Giles TD. Nifedipine-associated myocardial ischemia or infarction in the treatment of hypertensive urgencies. Ann Intern Med. 1987 Aug;107(2):185-186.
35. Zeller KR, Von Kuhnert L, Matthews C. Rapid reduction of severe asymptomatic hypertension. A prospective, controlled trial. Arch Intern Med. 1989 Oct;149(10):2186-2189.
36. Handler J. Hypertensive emergency with cardiac tamponade associated with hypothyroidism. J Clin Hypertens (Greenwich). 2007 Jan;9(1):67-72.
37. Narotam PK, Puri V, Roberts JM, Taylon C, Vora Y, Nathoo N. Management of hypertensive emergencies in acute brain disease: evaluation of the treatment effects of intravenous nicardipine on cerebral oxygenation. J Neurosurg. 2008 Dec;109(6): 1065-1074.
38. Axon RN, Garrell R, Pfahl K, et al. Attitudes and practices of resident physicians regarding hypertension in the inpatient setting. J Clin Hypertens (Greenwich). 2010 Sep;12(9): 698-705.
39. Weder AB, Erickson S. Treatment of hypertension in the inpatient setting: use of intravenous labetalol and hydralazine. J Clin Hypertens (Greenwich). 2010 Jan;12(1):29-33.
40. Khan MH, Kunselman AR, Leuenberger UA, et al. Attenuated sympathetic nerve responses after 24 hours of bed rest. Am J Physiol Heart Circ Physiol. 2002 Jun;282(6):H2210-H2215.
41. Rodriguez MA, Kumar SK, De Caro M. Hypertensive crisis. Cardiol Rev. 2010 Mar-Apr;18(2):102-107.
42. Volhard F, Fahr T. Bright’s Kidney Disease: Clinical Pathology and Atlas [in German]. Die Brightsche Nierenkrankheit: Klinik, Pathologie und Atlas. Berlin, Germany: Julius Springer; 1914: 247-280.
43. Woods JW. Malignant hypertension: clinical recognition and management. Cardiovasc Clin. 1978;9(1):311-320.
44. Gillespie CD, Hurvitz KA; Centers for Disease Control and Prevention (CDC). Prevalence of hypertension and controlled hypertension-United States, 2007-2010. MMWR Surveill Summ. 2013 Nov 22;62 Suppl 3:144-148.
45. Keith NM, Wagener HP, Keronohan JW. The syndrome of malignant hypertension. Arch Intern Med. 1928; 41: 264-278.
46. Gifford RW. Management and treatment of malignant hypertension and hypertensive emergencies. In: Genest J, Koiw E, Kuchel O, eds. Hypertension: Physiopathology and Treatment. New York, NY: McGraw-Hill; 1977: 1024-1042.
47. Benson JE, Gerlach AT, Dasta JF. National survey of acute hypertension management. Crit Care Shock. 2008;11(4): 154-166.
48. Center for Outcomes Research, University of Massachusetts Medical School. Studying the Treatment of Acute hyperTension (STAT) Registry website. http://www.outcomes.org/stat. Published 2007. Updated September 8, 2010. Accessed September 19, 2014.